Rosiglitazone and myocardial infarction: cause for concern or misleading meta-analysis?

被引：7

作者：

Bilous, R. W. ^{[1
]}

机构：

[1] James Cook Univ Hosp, Middlesbrough, Cleveland, England

来源：

DIABETIC MEDICINE | 2007年 / 24卷 / 09期

关键词：

D O I：

10.1111/j.1464-5491.2007.02259.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：931 / 933

页数：3

共 21 条

[1]

[Anonymous], 2007, LANCET, V369, P1834, DOI [10.1016/S0140-6736(07)60787-9, 10.1056/NEJMoao66224]

[2] Misleading meta-analysis: a need to look beyond the headlines [J].

Chaturvedi, N. ;

Bilous, R. ;

Hardy, R. ;

Remuzzi, G. ;

Ruggenenti, P. ;

Viberti, G. C. .

DIABETIC MEDICINE, 2007, 24 (06) :587-591

[3] Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial [J].

Dormandy, JA ;

Charbonnel, B ;

Eckland, DJA ;

Erdmann, E ;

Massi-Benedetti, M ;

Kmoules, IK ;

Skene, AM ;

Tan, MH ;

Lefébvre, PJ ;

Murray, GD ;

Standl, E ;

Wilcox, RG ;

Wlhelmsen, L ;

Betteridge, J ;

Birkeland, K ;

Golay, A ;

Heine, RJ ;

Korányi, L ;

Laakso, M ;

Mokán, M ;

Norkus, A ;

Pirags, V ;

Podar, T ;

Scheen, A ;

Scherbaum, W ;

Schernthaner, G ;

Schmitz, O ;

Skrha, J ;

Smith, U ;

Taton, J .

LANCET, 2005, 366 (9493) :1279-1289

[4] Rosiglitazone - Continued uncertainty about safety [J].

Drazen, Jeffrey M. ;

Morrissey, Stephen ;

Curfman, Gregory D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :63-64

[5] Faster publication isn't always better [J].

Fuster, Valentin ;

Farkouh, Michael E. .

NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2007, 4 (07) :345-345

[6] Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:: a randomised controlled trial [J].

Gerstein, H. C. ;

Yusuf, S. ;

Holman, R. R. ;

Bosch, J. ;

Anand, S. ;

Avezum, A. ;

Budaj, A. ;

Chiasson, J. ;

Conget, I. ;

Dagenais, G. ;

Davis, M. ;

Diaz, R. ;

Dinccag, N. ;

Enjalbert, M. ;

Escalante, A. ;

Fodor, G. ;

Hanefeld, M. ;

Hedner, T. ;

Jolly, K. ;

Keltai, M. ;

Laakso, M. ;

Lanas, F. ;

Lonn, E. ;

McQueen, M. ;

Mohan, V. ;

Phillips, A. ;

Piegas, L. ;

Pirags, V. ;

Probstfield, J. ;

Shaw, J. ;

Schmid, I. ;

Teo, K. ;

Zimmet, P. ;

Zinman, B. ;

Gerstein, H. C. ;

Yusuf, S. ;

Bosch, J. ;

Pogue, J. ;

Sheridan, P. ;

Dinccag, N. ;

Hanefeld, M. ;

Hoogwerf, B. ;

Laakso, M. ;

Mohan, V. ;

Shaw, J. ;

Zinman, B. ;

Holman, R. R. ;

Diaz, R. ;

Ahuad Guerrero, R. ;

Albisu, J. .

LANCET, 2006, 368 (9541) :1096-1105

[7]

*GLAXOSMITHKLINE, ZM20050018101 GLAXOS

[8] Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis [J].

Home, Philip D. ;

Pocock, Stuart J. ;

Beck-Nielsen, Henning ;

Gomis, Ramon ;

Hanefeld, Markolf ;

Jones, Nigel P. ;

Komajda, Michel ;

McMurray, John J. V. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (01) :28-38

[9]

*INF CTR, 2007, REP PRESCR DIAB PRIM

[10] Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy [J].

Kahn, Steven E. ;

Haffner, Steven M. ;

Heise, Mark A. ;

Herman, William H. ;

Holman, Rury R. ;

Jones, Nigel P. ;

Kravitz, Barbara G. ;

Lachin, John M. ;

O'Neill, M. Colleen ;

Zinman, Bernard ;

Viberti, Giancarlo .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2427-2443

← 1 2 3 →